Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IQVIA HOLDINGS INC.

(IQV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IQVIA : Baird Adjusts IQVIA Holdings' Price Target to $285 From $273, Keeps Outperform Rating

07/28/2021 | 11:49am EDT


ę MT Newswires 2021
All news about IQVIA HOLDINGS INC.
10/25IQVIA : Barclays Adjusts IQVIA Holdings' Price Target to $287 from $285, Keeps Overweight ..
MT
10/22IQVIA : Morgan Stanley Adjusts Price Target on IQVIA Holdings to $290 from $280, Keeps Ove..
MT
10/22IQVIA : Management's Discussion and Analysis of Financial Condition and Results of Operati..
AQ
10/21IQVIA : Q3 2021 IQVIA Earnings Conference Call Presentation
PU
10/21Health Care Stocks Steady Pre-Bell Thursday
MT
10/21IQVIA : Q3 Adjusted Earnings, Revenue Rise; Issues Q4 Outlook; Raises Full-Year 2021 Guida..
MT
10/21IQVIA : Q3 Earnings Snapshot
AQ
10/21IQVIA : Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance - Form 8-K
PU
10/21IQVIA HOLDINGS INC. : Results of Operations and Financial Condition (form 8-K)
AQ
10/21IQVIA : Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance
BU
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2021 13 827 M - -
Net income 2021 907 M - -
Net Debt 2021 10 665 M - -
P/E ratio 2021 55,2x
Yield 2021 -
Capitalization 49 145 M 49 145 M -
EV / Sales 2021 4,33x
EV / Sales 2022 3,93x
Nbr of Employees 77 000
Free-Float 74,2%
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 257,25 $
Average target price 285,94 $
Spread / Average Target 11,2%
EPS Revisions
Managers and Directors
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
W. Richard Staub President-Research & Development Solutions
Kevin C. Knightly President-Technology & Commercial Solutions
Sector and Competitors
1st jan.Capi. (M$)
IQVIA HOLDINGS INC.43.58%49 145
MODERNA, INC.234.60%141 099
LONZA GROUP AG31.93%60 646
SEAGEN INC.0.22%31 933
CELLTRION, INC.-39.69%25 328
ALNYLAM PHARMACEUTICALS, INC.53.63%23 730